Arca
Skip to content

Toothache

Drug research and approvals for toothache: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 17 studies of toothache are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 17
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 17 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

5 approved, 7 in phase 3, 9 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Acetaminophen, Ibuprofen, Naproxen, Benzocaine, Aspirin

Diclofenac
Phase 3 Cyclooxygenase inhibitor
Bupivacaine
Phase 3 Sodium channel protein type IV alpha subunit blocker
Codeine
Phase 3 Opioid receptors; mu/kappa/delta agonist
Tramadol
Phase 3 Mu opioid receptor agonist
Caffeine
Phase 3 Adenosine receptor antagonist
Etoricoxib
Phase 3 Cyclooxygenase-2 inhibitor
GW-406381
Phase 3 Cyclooxygenase-2 inhibitor
Celecoxib
Phase 2 Cyclooxygenase-2 inhibitor
Oxycodone
Phase 2 Mu opioid receptor agonist
ARRY-797
Phase 2 MAP kinase p38 alpha inhibitor
Buprenorphine
Phase 2 Mu opioid receptor agonist
Indomethacin
Phase 2 Cyclooxygenase inhibitor
Meloxicam
Phase 2 Cyclooxygenase-2 inhibitor
SB-705498
Phase 2 Vanilloid receptor antagonist
PF-05089771
Phase 2 Sodium channel protein type IX alpha subunit blocker
PF-04531083
Phase 2 Sodium channel protein type X alpha subunit blocker
Cannabidiol
Phase 1 Cannabinoid CB1 receptor negative allosteric modulator

How Its Trials Ended

98 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 34 whose ending is known, 79% met their primary endpoint, 0% missed it and 21% stopped early.

  • Completed, result not reported5556%
  • Met its primary endpoint2728%
  • Ongoing77%
  • Stopped: other or unclear44%
  • Stopped: enrollment or feasibility22%
  • Status unknown22%
  • Stopped: lack of efficacy11%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.